Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
about
Care-seeking patterns for fatal malaria in TanzaniaBrands, costs and registration status of antimalarial drugs in the Kenyan retail sectorDecreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania.Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural TanzaniaAre patent medicine vendors effective agents in malaria control? Using lot quality assurance sampling to assess quality of practice in Jigawa, NigeriaPrevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidiesInsights into the Affordable Medicines Facility-malaria in Ghana: the role of caregivers and licensed chemical sellers in four regionsImprovements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.Malaria treatment in the retail sector: knowledge and practices of drug sellers in rural Tanzania.Access to health care in contexts of livelihood insecurity: a framework for analysis and action.Understanding and improving access to prompt and effective malaria treatment and care in rural Tanzania: the ACCESS Programme.Engaging the private sector in malaria surveillance: a review of strategies and recommendations for elimination settings.Factors influencing implementation of the Ministry of Health-led private medicine retailer programmes on malaria in KenyaA pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops.Retail sector distribution chains for malaria treatment in the developing world: a review of the literatureDrugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: implications for malaria treatment policy."We have become doctors for ourselves": motives for malaria self-care among adults in southeastern Tanzania.Potential barriers to healthcare in Malawi for under-five children with cough and fever: a national household surveyDrug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.Artemisinin combination therapies price disparity between government and private health sectors and its implication on antimalarial drug consumption pattern in Morogoro Urban District, Tanzania.The quest for universal access to effective malaria treatment: how can the AMFm contribute?Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam.Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved?Molecular monitoring of resistant dhfr and dhps allelic haplotypes in Morogoro and Mvomero districts in south eastern Tanzania.Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilanceSaleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT)The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.The ACTwatch project: methods to describe anti-malarial markets in seven countriesMonitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countriesMedia, health workers, and policy makers' relationship and their impact on antimalarial policy adoption: a population genetics perspective.Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions.Patterns of treatment-seeking behaviors among caregivers of febrile young children: a Ugandan multiple case studyMethods for implementing a medicine outlet survey: lessons from the anti-malarial marketDiscovering the cost of care: consumer, provider, and retailer surveys shed light on the determinants of malaria health-seeking behavioursArtemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countriesAdverse drug events resulting from use of drugs with sulphonamide-containing anti-malarials and artemisinin-based ingredients: findings on incidence and household costs from three districts with routine demographic surveillance systems in rural TanzDrug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter?Concentration and drug prices in the retail market for malaria treatment in rural Tanzania.Comparative analysis of two methods for measuring sales volumes during malaria medicine outlet surveys.Introducing rapid tests for malaria into the retail sector: what are the unintended consequences?
P2860
Q24800766-B285E24A-E92F-446E-BB31-458C4206FCC4Q24816733-5FC05BD3-0234-44A3-AA27-BF4AF0F6C599Q28210310-7D2BF268-6F19-4B4B-9CCE-DB96071FD412Q28476037-80A390C8-006F-444D-91CA-2A37BF9652DDQ28483689-96CBF600-4458-4757-8A3B-8FBD94317AB8Q28537811-8730C3B6-E26A-4DBB-B4C3-14C4638482FBQ28833185-CB416DD0-1B95-4F34-8B12-F2FBF99B49B6Q30396834-60E85C29-CB6C-4078-90F5-976B28831F00Q30397987-E48667FC-F916-46AD-8E1B-059BCE4D4D87Q30398399-E626FC87-94B7-4C22-BA19-7FB8017E817AQ30398478-F76AA3B9-F511-4A34-B5B2-13BCDD0FD286Q30855800-238FB75F-04B1-4D29-A2FD-DF7AF8C29003Q33533983-4A65CD02-DC52-428E-BEFB-9D60032DBA63Q33623062-D8ABC2A4-F407-410E-B3B3-1311782CB61FQ33718659-65321618-8BDE-43F6-B965-F3CEB36436CCQ33838851-27E12C74-DC53-4446-A193-35274D1FD2B4Q33857957-0D49367C-5E2D-4439-9F28-B96E2BEB55D4Q33871075-15A7D756-8136-4D09-A44A-05F1B700B00BQ34014169-7D12CE69-5623-4E0B-BCF5-EFF1446E27FAQ34210653-53AD1DE7-B8EF-49E4-8206-F6D62A38D91CQ34221877-E9F2A417-6DDF-4812-8545-BFCD7B676E88Q34557276-4159AFD2-816D-46CF-99EE-3C254F9176B9Q34731553-13601827-F232-442D-A673-D03715793BA3Q35171924-F446B823-165D-46A2-B92E-008DBA26E29EQ35183422-8B6196B4-0542-4F9D-B30B-1CADAAE24EA1Q35198733-ECC512BD-5683-47D4-9A0F-8ED000785C0CQ35541212-902F7705-0FC1-4F44-BAB3-C780D4A686F1Q35554925-B50898A0-0155-4184-A5CE-D1EC164B03DDQ35570396-809CEED3-C786-4D45-9034-7E13516C1733Q35755266-01CD44A3-4296-4228-91C7-AEBEB502D0BDQ35800877-9A60BE74-7755-4F09-90FA-3A916F81ECF9Q35925393-F955F187-B691-4133-BF28-1749A1EB3FB4Q36690617-7511AC85-E6D5-482E-BB90-FABD743AEC97Q36714544-EDF10E44-B012-4E14-8897-3DB07DB2D6E5Q36799407-A54958FD-6C99-4A56-B182-A044FA1B8C45Q37009500-4F9D61FA-D486-4591-AB13-A4C91A803919Q37133736-6EB5DF20-110B-42E6-9D49-A4C02AE9C533Q37210171-7948E3A7-3D25-462E-8B07-568EF6B18485Q37359525-C71A844C-AA57-4B68-BA02-FD2D9EADDAABQ37659926-CD1F866E-EC49-489E-BE40-D247C9B968D0
P2860
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
@en
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
@en-gb
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
@nl
type
label
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
@en
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
@en-gb
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
@nl
prefLabel
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
@en
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
@en-gb
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
@nl
P2093
P2860
P1476
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
@en
P2093
Catherine Goodman
Eleuther Mwageni
Joanna A Schellenberg
Joyce Nyoni
Peter Bloland
Salim Abdulla
P2860
P304
P356
10.1111/J.1365-3156.2004.01245.X
P577
2004-06-01T00:00:00Z